We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTW:NASDAQWillis Towers Watson Public Limited Company Analysis

Data as of 2026-03-10 - not real-time

$291.83

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Willis Towers Watson is trading at $291.83, comfortably above its 20‑day, 50‑day and 200‑day moving averages, signaling a short‑term bearish technical stance. However, the stock posted a Q4 EPS of $8.12, beating consensus estimates, and analysts maintain a "Buy" rating with a median target of $370, implying roughly 27% upside. The RSI sits near 40, hinting at modest downside risk, while the MACD histogram turned positive, offering a hint of bullish momentum. Fundamentally, the company delivers a solid 20% ROE, a low payout ratio of 22%, and a dividend yield of 1.3%, which appears sustainable given its strong operating cash flow. Valuation metrics are mixed: the trailing P/E of 17.9 is slightly above the industry average, yet the forward P/E of 13 suggests earnings acceleration, and the DCF fair value of $238 marks the current price as potentially overvalued. High 30‑day volatility (≈50%) and a decreasing volume trend raise short‑term risk, but the low beta (~0.35) dampens market‑wide swings. Overall, the stock balances growth drivers from earnings beats and a strong dividend with technical weakness and valuation concerns, positioning it for a cautious but optimistic outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages indicating bearish technical bias
  • Earnings beat and strong cash flow support near‑term stability
  • High short‑term volatility and declining volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst median target of $370 suggests ~27% upside
  • Forward P/E compression indicating earnings acceleration
  • Sustainable dividend and low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistently high ROE and solid operating margins
  • Diversified advisory and broking franchise with resilient cash generation
  • Dividend yield and low payout ratio provide income stability

Key Metrics & Analysis

Financial Health

Revenue Growth-3.30%
Profit Margin16.53%
P/E Ratio17.9
ROE20.08%
ROA4.83%
Debt/Equity85.75
P/B Ratio3.5
Op. Cash Flow$1.8B
Free Cash Flow$1.9B
Industry P/E17.4

Technical Analysis

TrendBearish
RSI40.1
Support$275.60
Resistance$310.02
MA 20$296.78
MA 50$314.21
MA 200$319.95
MACDBullish
VolumeDecreasing
Fear & Greed Index80.86

Valuation

Fair Value$238.05
Target Price$369.42
Upside/Downside26.59%
GradeOvervalued
TypeBlend
Dividend Yield1.30%

Risk Assessment

Beta0.35
Volatility50.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.